AI assistant
Syngene International Limited — Call Transcript 2020
May 5, 2020
61231_rns_2020-05-05_85ea0498-4938-47eb-9182-124257797b79.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [112 x 28] intentionally omitted <==
Ref: Syn/CS/SE/Reg 30/2020-21/May/10
Syngene International Limited
May 05, 2020
Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India T +91 80 6775 8000 F +91 80 6775 8808 CIN: L85110KA1993PLC01493 www.syngeneintl.com
| To, The Manager, BSE Limited Corporate Relationship Department Dalal Street,Mumbai – 400 001 |
To, The Manager, National Stock Exchange of India Limited Corporate Communication Department Bandra(EAST),Mumbai – 400 051 |
|---|---|
| Scrip Code: 539268 | Scrip Symbol: SYNGENE |
Subject: Intimation of Conference Call for Analysts and Investors
Dear Sir/Madam,
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for conference call for analysts and investors to be held on Wednesday, May 13, 2020.
The above-mentioned information will also be available on website of the Company www.syngeneintl.com.
Request to kindly take this intimation on record.
Thanking You,
Yours faithfully,
For SYNGENE INTERNATIONAL LIMITED
PRIYADARSH Digitally signed by PRIYADARSHINI INI MAHAPATRA MAHAPATRA Date: 2020.05.05 18:31:10 +05'30'
______ Priyadarshini Mahapatra
Company Secretary and Compliance Officer
INVESTOR CONFERENCE CALL INVITE Q4 FY 2019-20
==> picture [594 x 151] intentionally omitted <==
Syngene’s Q4 & Full Year FY2020 Results Conference Call
At 02:45 pm IST on 13[th ] May, 2020
The management team of Syngene International Limited (“Syngene”) will organize a conference call for Analysts and Investors on Wednesday, 13th May at 02:45 pm IST following the announcement of financial results for the quarter and the year ended March 31, 2020.
The call will be initiated with a brief management discussion on the Q4 and full year FY2020 performance followed by an interactive Question & Answer session. Mr. Jonathan Hunt - Syngene’s Managing Director and Chief Executive Officer and other members of the senior management team will represent Syngene on the conference call.
Details of the conference call are as under:
| Date: | Thursday, 13th May 2020 |
|---|---|
| Time: | 02:45 pm to 03:30 pm IST |
| Dial-in Numbers: | |
| Primary Number | +91 22 6280 1279 / +91 22 7115 8180 |
| Local Access Number | +91 70 4567 1221:Available all over India (Accessible from all carriers.) |
| International Toll Free Numbers | • USA – 18667462133/+13233868721 • UK – 08081011573/+442034785524 • Singapore – 8001012045/+6531575746 • Hong Kong – 800964448/+85230186877 |
Syngene International: Putting Science to Work
Page 1
INVESTOR CONFERENCE CALL INVITE Q4 FY 2019-20
==> picture [594 x 151] intentionally omitted <==
| Pre-registration Facility | Step 1: Pre-register here.You will receive a passcode and a pin for the call on the registered email address. Step 2: Dial into the call on the Conference Call date, enter the passcode & pin as prompted. You will be directly connected to the call |
|
|---|---|---|
| Replay Facility | Dial in numbers: +91 22 7194 5757 / +91 22 6663 5757 Playback ID:08093 The replay facility will be available from 13th May 2020 till 22nd May 2020 |
|
| Conference Call Transcript | Will be available within 7 working days of the call on the corporate website:www.syngeneintl.com |
About Syngene
Syngene International Ltd. ( BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022 ), is an innovation-focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of over 3500 scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed up time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.
For further information, please contact:
Sapna H.B Syngene International : +91 80 6775 9807 : [email protected]
Disclaimer: Certain of the statements that may be made or discussed at the conference call may be forwardlooking statements and/or based on management’s current expectations and beliefs concerning future developments and their potential effects upon Syngene and its associates. There can be no assurance that future developments affecting Syngene and its associates will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties and there are important factors that could cause actual results to differ, possibly materially, from expectations reflected in such forward-looking statements. Syngene does not intend, and is under no obligation, to update any particular forward-looking statement made at the conference call.
Syngene International: Putting Science to Work
Page 2